JPMORGAN CHASE & CO - GEMPHIRE THERAPEUTICS INC ownership

GEMPHIRE THERAPEUTICS INC's ticker is GEMP and the CUSIP is 36870A108. A total of 29 filers reported holding GEMPHIRE THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of GEMPHIRE THERAPEUTICS INC
ValueSharesWeighting
Q4 2017$11,000
-86.1%
1,401
-83.2%
0.00%
Q3 2017$79,000
+276.2%
8,317
+419.8%
0.00%
Q2 2017$21,0001,6000.00%
Other shareholders

There were no reported owners of GEMPHIRE THERAPEUTICS INC in Q4 2017.

NameSharesValueWeighting ↓
View complete list of GEMPHIRE THERAPEUTICS INC shareholders